Opinion | ‘Is It Safe to Hit a Kid in the Head 200 Times?’: What We Heard This Week

“Is it safe to hit a kid in the head 200 times?” — Chris Nowinski, PhD, of the Concussion Legacy Foundation in Boston, on head trauma in youth football.

“These laws are just incompatible with evidence-based medical care, and the bans need to be repealed.” — Daniel Grossman, MD, of Advancing New Standards in Reproductive Health, how the elimination of federal abortion protections changed obstetric care.

“At least for some patients, Parkinson’s disease may originate in the gut.” — Trisha Pasricha, MD, MPH, of Beth Israel Deaconess Medical Center in Boston, on the link between upper gastrointestinal damage and subsequent Parkinson’s diagnoses.

“That would indicate a step up in the virus’ game.” — James Lawler, MD, MPH, of the University of Nebraska Medical Center’s Global Center for Health Security in Omaha, if the H5 bird flu is passed by human-to-human transmission.

“It tells us that chronic pain, in and of itself, is not depressing.” — Rachel Aaron, PhD, of Johns Hopkins University School of Medicine in Baltimore, on kids with chronic pain who have anxiety and depression.

“You do liposuction in a way that accentuates the desirable contours of the body.” — Neil Tanna, MD, of the Katz Women’s Surgical Center at Northwell Health in New York, on surgically creating six-pack abs.

“Carbapenem resistance is a thing and it’s far worse now than it was 10 years ago.” — Michael Green, MD, MPH, of the UPMC Children’s Hospital of Pittsburgh and FDA advisor, discussing an investigational urinary tract infection antibiotic.

“A patient has to be alive to develop a second malignancy.” — Kai Rejeski, MD, Memorial Sloan Kettering Cancer Center in New York City, on risks associated with CAR T-cell therapy for cancer.

“There seems to be similar effects with semaglutide.” — Luis-Emilio García-Pérez, MD, PhD, of Eli Lilly in Indianapolis, on sex differences with weight loss from tirzepatide (Zepbound).

Please enable JavaScript to view the

comments powered by Disqus.